SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001564590-19-045172
Filing Date
2019-12-03
Accepted
2019-12-03 17:29:35
Documents
6
Period of Report
2019-11-26
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 4.01: Changes in Registrant's Certifying Accountant
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K insy-8k_20191126.htm 8-K 67239
2 EX-2.1 insy-ex21_9.htm EX-2.1 326532
3 EX-16.1 insy-ex161_8.htm EX-16.1 5195
4 EX-99.1 insy-ex991_6.htm EX-99.1 970225
5 EX-99.2 insy-ex992_7.htm EX-99.2 1414990
6 GRAPHIC g1kowcfqhg3m000001.jpg GRAPHIC 107576
  Complete submission text file 0001564590-19-045172.txt   2933725
Mailing Address 10220 SOUTH 51ST STREET SUITE 2 PHOENIX AZ 85044
Business Address 10220 SOUTH 51ST STREET SUITE 2 PHOENIX AZ 85044 602-910-2617
Insys Therapeutics, Inc. (Filer) CIK: 0001516479 (see all company filings)

IRS No.: 510327886 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-35902 | Film No.: 191266554
SIC: 2834 Pharmaceutical Preparations